Identification and Phenotypic Characterization of a β-Lactam-Dependent, Methicillin-Resistant Staphylococcus aureus Strain
- 1 July 2007
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 51 (7), 2514-2522
- https://doi.org/10.1128/aac.00040-07
Abstract
Methicillin resistance in Staphylococcus aureus is primarily mediated by the acquired penicillin-binding protein PBP 2a, which is encoded by mecA. PBP 2a acts together with native PBP 2 to mediate oxacillin resistance by contributing complementary transpeptidase and transglycosylase activities, respectively. In this study, we have investigated a phenotype of beta-lactam dependence in a clinical methicillin-resistant S. aureus strain (strain 2884D) obtained by in vitro selection with ceftobiprole. 28884D, which grew very poorly in blood agar, required the presence of the beta-lactam antibiotics to grow. On the basis of this observation, we hypothesized that a gene or genes essential for growth were dependent on oxacillin induction. Identification and analysis of genes regulated by oxacillin were performed by both real-time reverse transcription-PCR and spotted microarray analysis. We found that mecA was constitutively expressed in strain 2884D and that the constitutive expression resulted from perturbations in the two systems involved in its regulation, i.e., MecI/MecR1 (staphylococcal chromosome cassette mec type I) and BlaI/BlaR1 (nonfunctional penicillinase operon). PBP 2 appeared to be poorly induced by oxacillin in 2884D. Further analysis of the PBP 2 two-component VraSR regulatory system showed that it was nonfunctional, accounting for the lack of response to oxacillin. Together, these results support the notion that limited PBP 2 availability may have led 2884D to become dependent on oxacillin-mediated mecA induction as a required survival mechanism.Keywords
This publication has 46 references indexed in Scilit:
- Role of VraSR in Antibiotic Resistance and Antibiotic-Induced Stress Response in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2006
- VraSR Two-Component Regulatory System and Its Role in Induction of pbp2 and vraSR Expression by Cell Wall Antimicrobials in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2006
- In Vitro Activities of a Novel Cephalosporin, CB-181963 (CAB-175), against Methicillin-Susceptible or -Resistant Staphylococcus aureus and Glycopeptide-Intermediate Susceptible StaphylococciAntimicrobial Agents and Chemotherapy, 2004
- Related Clones Containing SCC mec Type IV Predominate among Clinically Significant Staphylococcus epidermidis IsolatesAntimicrobial Agents and Chemotherapy, 2003
- Quantitation of mecA Transcription in Oxacillin-Resistant Staphylococcus aureus Clinical IsolatesJournal of Bacteriology, 2003
- In Vitro Activity of Cephalosporin RWJ-54428 (MC-02479) against Multidrug-Resistant Gram-Positive CocciAntimicrobial Agents and Chemotherapy, 2002
- Complementation of the Essential Peptidoglycan Transpeptidase Function of Penicillin-Binding Protein 2 (PBP2) by the Drug Resistance Protein PBP2A in Staphylococcus aureusJournal of Bacteriology, 2001
- In Vitro and In Vivo Properties of Ro 63-9141, a Novel Broad-Spectrum Cephalosporin with Activity against Methicillin-Resistant StaphylococciAntimicrobial Agents and Chemotherapy, 2001
- An Outbreak of Vancomycin-Dependent Enterococcus faecium in a Bone Marrow Transplant UnitClinical Infectious Diseases, 1999
- Massive Reduction in Methicillin Resistance by Transposon Inactivation of the Normal PBP2 in a Methicillin-Resistant Strain ofStaphylococcus aureusMicrobial Drug Resistance, 1997